Back to top
more

Stryker (SYK)

(Delayed Data from NYSE)

$307.80 USD

307.80
3,427,831

+6.66 (2.21%)

Updated Jun 18, 2026 04:00 PM ET

After-Market: $307.00 -0.80 (-0.26%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 29% (175 out of 247)

Industry: Medical - Products

Zacks News

Zacks Equity Research

Can Neurotechnology & Spine Drive Stryker (SYK) Q1 Earnings?

Stryker's (SYK) Neurotech business goes strong, VEXIM buyout likely to boost segment.

    Zacks Equity Research

    Will Core Segmental Growth Aid Stryker (SYK) in Q1 Earnings?

    Stryker's (SYK) acquisition-driven strategy is likely to boost Q1 results through the expansion of product offerings.

      Zacks Equity Research

      Stryker Loses 7.6% in a Month: What's Weighing It Down?

      Stryker's (SYK) declining margins and demand for healthcare products raise concern.

        Zacks Equity Research

        Orthopedic Device Market Gains Momentum: 3 Stocks in Focus

        The orthopedics market holds immense potential for investors who are keen on the healthcare space for long-term gains.

          Zacks Equity Research

          Stryker Closes Entellus Buyout, Bolsters Neurotechnology Line

          Stryker (SYK) maintains its acquisition-driven strategy to provide superior and more economic patient experiences.

            Zacks Equity Research

            Stryker (SYK) Beats Earnings and Revenue Estimates in Q4

            Stryker's (SYK) Q4 results benefit from Mako product platform and higher organic sales.

              Zacks Equity Research

              MedTech Stock Q4 Earnings Slated for Jan 30: SYK, ZBH, ALGN

              The Medical sector is expected to stand out on favorable consumer behavior, growing prevalence of minimally-invasive surgeries, demand for liquid biopsy tests, and a value-based payment system.

                Zacks Equity Research

                Will Core Segmental Growth Aid Stryker (SYK) in Q4 Earnings?

                Stryker's (SYK) robust fundamentals and broad product scale are likely to drive performance in the Q4. However, the company faces product-recall issues.

                  Mark Vickery headshot

                  Top Research Reports for Microsoft, Philip Morris and 3M

                  Today's Research Daily features new research reports on 16 major stocks, including Microsoft (MSFT), Philip Morris (PM) and 3M (MMM).

                    Zacks Equity Research

                    MedTech Tax Resumes in 2018, 3 Stocks to Suffer

                    Sectors that are likely to be hampered the most by the re-imposition of the medical device tax are X-ray and MRI machines, surgical instruments and pacemakers.